EGFR and prostate carcinoma: Mechanistically, TGFα, a member of the epidermal growth factor (EGF) family, was shown to bind to the EGFR leading to a significant AKT activation in the late-stage prostate cancer cells, whereas stimulation of early-stage prostate cancer cells with EGF diminishes AKT activation.